Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia.
Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S. Soga Y, et al. Among authors: sugiura y. Support Care Cancer. 2009 May;17(5):581-7. doi: 10.1007/s00520-008-0532-z. Epub 2008 Nov 18. Support Care Cancer. 2009. PMID: 19015893 Free article.
Antimicrobial effects of the saliva substitute, Oralbalance, against microorganisms from oral mucosa in the hematopoietic cell transplantation period.
Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Nishide S, Kono K, Takahashi K, Fujii N, Ishimaru F, Tanimoto M, Yamabe K, Tsutani S, Nishimura F, Takashiba S. Sugiura Y, et al. Support Care Cancer. 2008 Apr;16(4):421-4. doi: 10.1007/s00520-007-0391-z. Epub 2008 Jan 16. Support Care Cancer. 2008. PMID: 18197430
With regard to our manuscripts on the commercial saliva substitute, Oralbalance®--its formula has been changed.
Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Morishige-Nishide S, Itami-Kono K, Takahashi K, Fujii N, Ishimaru F, Tanimoto M, Yamabe K, Tsutani S, Nishimura F, Takashiba S. Sugiura Y, et al. Support Care Cancer. 2014 Dec;22(12):3121-2. doi: 10.1007/s00520-014-2432-8. Epub 2014 Sep 20. Support Care Cancer. 2014. PMID: 25239598 Free article. No abstract available.
Single-Molecule Oxidoreductase Activity Analysis for Activity-Based Diagnosis Based on Proteoform Alterations.
Minoda M, Hatakeyama J, Nagano N, Mizuno T, Iwasaka T, Shiga S, Takahashi K, Hiraide H, Sakamoto S, Kagami Y, Kashiro A, Honda K, Sugiura Y, Mishima K, Mishima MK, Kusuhara H, Urano Y, Komatsu T. Minoda M, et al. Among authors: sugiura y. J Am Chem Soc. 2025 Jan 6. doi: 10.1021/jacs.4c07624. Online ahead of print. J Am Chem Soc. 2025. PMID: 39762186
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma.
Takagi S, Nakajima M, Koike S, Takami M, Sugiura Y, Sakata S, Baba S, Takemoto A, Huang T, Seto Y, Saito M, Funauchi Y, Ae K, Takeuchi K, Fujita N, Katayama R. Takagi S, et al. Among authors: sugiura y. Oncogene. 2024 Dec 11. doi: 10.1038/s41388-024-03251-6. Online ahead of print. Oncogene. 2024. PMID: 39663392
1,300 results